It is a key that hepatitis B treats a patient to manage for a long time

It is a key that hepatitis B treats a patient to manage for a long time
The reporter held by Bristol-Myers Squibb " The rich way is made ' Kindness take the place of the intersection of card and Wei block) Fifth anniversary and Chinese hepatitis B antiviral therapeutic reviews and prospects " Learn, though chronic hepatitis B is still difficult to effect a radical cure, the patient still needs to treat and follow up a case by regular visits to for a long time at media's presentation meeting, with the intersection of China and first parts of appearance and popularization of " chronic hepatitis B prevent and cure the guide ", potent low fast popularization which is able to bear the antiviral treatment idea of medicine in the past five years, break through, hinder our country from to be antiviral to treat two big bottleneck of development - medical personnel lack oppose virus treat the intersection of clinical practice and understanding and employ and resist for a long time of importance promptly The virus therapeutic medicine is able to bear medicines and influence the question of curative effect and define " treats the goal " in the long-term management of chronic hepatitis B With " treat the tactics " ,And improved the chronic hepatitis B in China and treated competence wholly. According to the intersection of Peking University and medical science department, the brightness professor in the village of the academician of Chinese Academy of Engineering introduces, hepatopathy department and infectious disease department doctor of most hospital of national the first, second and third realize the importance against virus treatment at present, and accept totally the chronic hepatitis B patient of antiviral treatment has exceeded 1 million; In addition, acute serious disease hepatitis patient and hepatocarcinoma, number of people of liver cirrhosis caused by chronic hepatitis B are obviously reduced because of popularization against virus treatment, not only has reduced the burden of patient and relative also reduced the national public health expenditure. " chronic hepatitis B prevent and cure the guide " clear " The antiviral treatment " It was a therapeutic foundation stone of chronic hepatitis B five years ago, our country's medical personnel and patient paid attention to slow hepatitis B more symptom caused was improved, for cause slow the intersection of hepatitis B and basic reason that disease develop and treat goal, have abundant understanding, thus lack the cognition of the antiviral treatment importance of hepatitis B. One is prevented and cured " prevailing current situation and relevant problem analysis report of Chinese hepatitis " that the foundation announced in June of 2005 to reveal by Chinese hepatitis, only 19% of the patients accepted the antiviral treatment at that time, were up to adopting Chinese medicine and assuaring the liver that the enzyme medicine treatment fell by investigators of 73%. Prevent and cure the important milestone of the development history Zhong as the chronic hepatitis B in China, of our country first part that issue will it be December 2005 " whether chronic hepatitis B prevent and cure the guide" ' Hereafter referred to as " The guide " ),Have defined the treatment goal of hepatitis B is to " inhibits the virus from duplicating effectively for the first time, delay disease progress, lighten hepatocyte inflammation and liver fiber, prevent and prevent liver cirrhosis, hepatocarcinoma from taking place, thus make the patient lengthen the time of surviving, improve life quality " ,And clear and prominent for the first time " The antiviral treatment " In the foundation stone position being treated of chronic hepatitis B. Over the past five years, with " guide " popularizing energetically in the specialist and popularization, the position against virus treatment has got obviously promotion in the clinical treatment. According to the introduction of brightness academician in the village, by 2008, 40% of the chronic hepatitis B patients accept the antiviral treatment in our country, compare, had doubled more than before releasing with " guide ". The chronic hepatitis B of emergence that the antiviral treatment reduces liver cirrhosis, hepatocarcinoma is a progressive disease, one show to 684 cases of chronic hepatitis B patient's prospective research, the annual incidence of estimation that the chronic hepatitis B patient develops into liver cirrhosis is 2.1%. Another one averages HBeAg negative chronic hepatitis B follow-up study in 9 years, it is 23% and 4.4% to develop respectively, and the liver cirrhosis incidence of HBeAg positive patient is higher than HBeAg the negative one. . In China, it is 1,152 yuan that each of patient of chronic hepatitis B treats the expenses annually, treating the expenses every year and reaching 1,500 yuan of early liver cirrhosis each of patient, look on as the condition is developed to later period liver cirrhosis, each person treats the expenses to reach 13,803 yuan every year, develop and treat the expenses every year each person and up to over 38,000 yuan to the patient of hepatocarcinoma finally. So, adopt the therapeutic tactics based on long-term disease result, will cause patient's family and country enormously to bear. The subsidiary old man of Huashan hospital infectious disease department heart Professor Hua of Fudan University says: "Treatment no can remove the intersection of hepatitis B and virus completely, can delay disease while being only method of progress to can keep, inhibit virus from duplicate for a long time at present, and then reduce the heavy-duty hepatitis B patient, and develop from chronic hepatitis B into the emergence of liver cirrhosis and hepatocarcinoma. " Have data reveal chronic the intersection of hepatitis B and patient accept rich way make After treat from 3 to 7, 96% the intersection of patient and the intersection of liver and inflammation lighten obviously, 88% the intersection of patient and the intersection of liver and fiber take, fail obviously, exist the intersection of liver and fiber of patient of liver cirrhosis to take, improve to some extent later period before the all treatment, and patient all these reach quantity can't measure competence ( lt year such as virus such as hepatitis B in not following up a case by regular visits to for a long time; 300 copy / ml) . It is able to bear the medicine medicine and let the antiviral treatment be possible in the past five years that it is potent and low, the important factor that another one advances the development of antiviral treatment is: It is potent and low to able to bear the appearance against virus treatment medicine of medicine and face the fast popularization in bed. Old man's heart Professor Hua introduces, taking the antiviral treatment orally and can be traced back to 12 years ago of Chinese hepatitis B. The hepatitis B of first of China is taken the antiviral treatment medicine Lammi orally the applies to the hepatitis B treatment formally definitely, take the prelude against virus treatment orally after pulling open Chinese hepatitis B. In short a a few years, the intersection of Lammi and let doctor and patient realize antiviral treatment the intersection of hepatitis B and one right way of treatment definitely. But able to bear clinical treatment that medicine lead to the fact, fail to let clinicians oppose the virus treatment and produce suspicion, let the patient worry, has hindered the antiviral treatment from facing in bed and furtherly and popularizing. The rich way listed on China five years ago is made ' Kindness take the place of the intersection of card and Wei block) Have represented Israel " It is able to bear medicines that it is potent and low " It is the antiviral therapeutic medicine of oral hepatitis B of new generation completely of the characteristic, there are clinical data that reveal, cure patient, accept the rich way is made for the first time ' Kindness take the place of the intersection of card and Wei block) After treating for 6 years, able to bear only 1.2% of medicine incidence totally, this data mean most chronic hepatitis B patients can reach and inhibit the virus from duplicating steadily in a long-term, have strengthened the confidence that the medical personnel carries on long-term disease management to the patient. Take the good future distance, it is a key that the patient manages for a long time Patient needs to manage chronic hepatitis B for a long time, this has been determined when doctor and patient are choosing the healing solution, need to consider curative effect, able to bear the three key factors of the long-term safety of medicine risk, medicine synthetically. At the the intersection of European and the intersection of hepatopathy and annual meeting, one accept to 1051 rich way make 2010 not finishing just in will it be April this year Treat (184 weeks, about 3.5 years) for a long time Hepatitis B patients chronic revealing whether make (last card Wei slice kindness) ways rich It is an antiviral therapeutic medicine with good tolerance. Old man's heart Professor Hua points out, because existing treatment means still fails to drive hepatitis B and virus in patient's body out completely, so if conditions permit for economy, should choose first potent, low and is able to bear the antiviral medicine that medicine, security are high, inhibit the virus from duplicating for a long time, delay disease to liver cirrhosis, hepatocarcinoma progress, improve patient's life quality, make them return to and live easily. One that is with hypertension, hyperglycemia different from unusually,etc. chronic supersession disease of the fat of blood is, chronic hepatitis B is disease initiated by the pathogen, but the one the same as the disease treatment is, the patients must all strengthen the compliance using medicine, comply with the doctor's order, not adjust the dosage or stop medicines at will. The brightness academician in the village thinks, improve patient's treatment, improve a patient's own disease managerial ability, it will be another key of taking the antiviral treatment future way of good hepatitis B. (Times reporter Liu QiaoBin of health)

|